Using the quantitative determination of HBsAg to predict the course of chronic hepatitis B in women during pregnancy and after childbirth
https://doi.org/10.22625/2072-6732-2013-5-2-50-54
Abstract
About the Authors
M. A. BelopolskayaRussian Federation
T. V. Volokobinskaya
Russian Federation
S. L. Firsov
Russian Federation
A. A. Yakovlev
Russian Federation
References
1. Kumar, M. Virological and histological features of chronic hepatitis B virus infected asymptomatic patients with persistently normal ALT / M. Kumar [et al.] // Gastroenterology. – 2008. – № 134. – P. 1376–1384.
2. Lavanchy, D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures / D. Lavanchy // J. Viral. Hepat. – 2004. – № 11. – P. 97–107.
3. Комарова, А.Я. Распространенность хронических вирусных гепатитов среди населения Санкт-Петербурга / А.Я. Комарова, А.А. Яковлев // Клин. перспективы гастроэнт., гепатол. – 2012. – № 5. – С. 34–40.
4. Chu, C. Hepatitis B surface antigen seroclearance during chronic HBV infection / C. Chu, Y. Liaw // Antivir Ther. – 2010. – № 15. – P. 133–143.
5. Seeger, C. Hepatitis B virus biology / C. Seeger, W. Mason // Microbiol Mol BiolRev. – 2000. – № 64. – P. 51–68.
6. Liaw, Y. Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: A review / Y. Liaw // Hepatology. – 2011. – № 53. – P. 2121–2129.
7. Tran, T. Management of hepatitis B in pregnancy: weighing the options / T. Tran // Cleve Clin J Med. – 2009. – № 76 (3). – P. 25–29.
Review
For citations:
Belopolskaya M.A., Volokobinskaya T.V., Firsov S.L., Yakovlev A.A. Using the quantitative determination of HBsAg to predict the course of chronic hepatitis B in women during pregnancy and after childbirth. Journal Infectology. 2013;5(2):50-54. (In Russ.) https://doi.org/10.22625/2072-6732-2013-5-2-50-54